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Introduction: Multidrug resistance (MDR) and emergence of extended-spectrum b-lactamases (ESBLs) that
mediate resistance to b-lactam drugs among Escherichia coli and other uropathogens have been reported
worldwide. However, there is little information on the detection of ESBLs genes in E. coli from patients with
urinary tract infections (UTIs) in the Arab countries using polymerase chain reaction (PCR), and in Libya such
information is lacking.
Methods: All patients attending Zawiya Teaching Hospital in Zawiya city between November 2012 and June
2013 suspected of having UTIs and from whom midstream urine samples were taken as part of the clinical
workup were included in this prospective study. Samples were examined for uropathogens by standard
bacteriological procedures. VITEK-2 automated microbiology system was used to identify the isolated
uropathogens and determine the susceptibility of E. coli and Klebsiella spp. isolates to antimicrobials. In
addition, phenotypically ESBLs-positive E. coli isolates were tested for ESBLs genes by PCR.
Results: The present study enrolled 1,790 patients with UTIs. Uropathogens were found in 371 (20.7%) urine
specimens examined. Mixed pathogens were detected in two specimens with 373 total pathogens isolated.
E. coli and Klebsiella spp. were the predominant uropathogens at 55.8% (208/373) and 18.5% (69/373),
respectively. Other pathogens were detected in 25.7% (96/373) of urine samples. Of the E. coli and Klebsiella
spp. tested, 69.2 and 100% were resistant to ampicillin, 6.7 and 33.3% to ceftriaxone, and 23.1 and 17.4% to
ciprofloxacin, respectively. MDR (resistance to ]3 antimicrobial groups) was found in 69 (33.2%) of E. coli
and in 29 (42%) of Klebsiella spp. isolates. ESBLs were detected phenotypically in 14 (6.7%) of E. coli and in
15 (21.7%) of Klebsiella spp. isolates. Thirteen out of the 14 phenotypically ESBL-positive E. coli were
positive for ESBL genes by PCR. blaTEM gene was detected in seven isolates, blaOXA gene in 10 isolates and
blaCTX-M gene in six isolates. blaSHV gene was not detected in the present study.
Conclusion: The isolation of MDR ESBL-producing uropathogens undoubtedly will limit the choices clinicians
have to treat their patients with UTIs. Therefore, there is an urgent need for surveillance studies on antimicrobial
resistance and prevalence of ESBLs among uropathogens to guide the clinical treatment of UTIs in Libya in the
future.
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O
ne of the most common reasons that patients in
the community seek medical care and prescribed
antibiotics is urinary tract infections (UTIs) (1).
Most UTIs are caused by members of the family
Enterobacteriaceae mainly Escherichia coli and Klebsiella
spp. High resistance rates to antimicrobials used in the
treatment of UTIs among E. coli and other uropathogens
have been reported worldwide, particularly in developing
countries including Libya (2). In recent years, the prob-
lem worsened due to the emergence of extended-spectrum
b-lactamases (ESBLs) that mediate resistance to b-lactam
antimicrobials, especially third generation cephalosporins
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among these organisms. Genes responsible for ESBLs
production arise by point mutation at the active site of
the earlier b-lactamases (e.g. TEM-1 and SHV-1 en-
zymes), and they are usually plasmid mediated (3, 4). In
addition, ESBLs-positive Gram-negative bacteria often
carry genes that confer high levels of resistance to many
other antibiotics (e.g. fluoroquinolones and aminoglyco-
sides) (5). Previous use of penicillins, cephalosporins or
quinolones is found to be a risk factor, among others, for
the development of ESBLs-producing bacteria in non-
hospitalized patients with community-acquired UTIs (6).
The epidemiology of antibiotic resistant bacteria, how-
ever, varies from region to region, from speciality to
speciality, from infection type to infection type, and from
year to year (7). Therefore, identification and determina-
tion of antimicrobial susceptibility of bacterial pathogens
in the local healthcare setting may aid the clinician in
selecting the appropriate antimicrobial agent (s) to treat his
patients.
Studies on the causative agents of UTIs in Libya and
their susceptibility to antimicrobial are few and were
mainly carried out in the two main cities in Libya (i.e.
Tripoli and Benghazi) (8, 9). Furthermore, there is little
information on the detection of ESBLs genes in E. coli
from patients with UTIs in the Arab countries using
molecular methods and in Libya such information is
lacking. Therefore, the aim of the present investigation
was to determine the prevalence of organisms associated
with UTIs in patients attending Zawiya Teaching Hospi-
tal (ZTH), their susceptibility to antimicrobial agents,
and the presence of ESBLs genes in E. coli isolates using
polymerase chain reaction (PCR).
Methods
Patients
All patients attending Zawiya Teaching Hospital in
Zawiya city suspected of having UTIs and from whom
urine samples were taken as part of the clinical workup
were included in this prospective study. The study was car-
ried out between November 2012 and June 2013. Zawiya
city is located in northwestern Libya, situated on the
Libyan coastline of the Mediterranean Sea about 45 km
west of Tripoli with an estimated population of about
200,000 people. ZTH has 400 beds and frequented mainly
by inhabitants of Zawiya city and surrounding cities and
villages.
In this investigation, urine specimens were collected
under approved ethical standards and the study was
reviewed and approved by the Academy of Graduate
Studies, Janzour, Tripoli, Libya.
Specimen collection
Urine specimens were obtained from all patients included
in the study with the assistance of a medical doctor or
senior nurse. Midstream urine was collected from patients
aged more than 1 year in a sterile container and processed
in the laboratory within 2 h of collection. Urine speci-
mens were obtained by suprapubic aspiration from
children who are not toilet trained and proceed as above.
The consent of the patients or that of their guardians was
obtained before urine specimens were collected.
Isolation and identification of uropathogens
Using calibrated loops (103 ml, Last Loop Sp, Italiana,
Italy), urine specimens were inoculated on to MacConkey
and blood agar plates. After 1824 h incubation at 378C,
the number of colony forming units (cfu) was counted, and
urine samples giving ]105 cfu/ml of urine were considered
significant. Isolated colonies from significant plates were
identified using the VITEK-2 automated microbiology
system (bioMérieux, Inc., Durham, NC, USA) employing
the GN and GP colorimetric reagent cards that are incu-
bated and interpreted automatically. The GN card is used
for identification of Gram-negative fermenting and non-
fermenting bacilli, and the GP card is used for identifica-
tion of Gram-positive cocci and non-spore forming bacilli.
Reference strains of E. coli ATCC 25922 and
Pseudomonas aeruginosa ATCC 27853 were used as con-
trols for the Gram-negative bacteria. Staphylococcus
aureus ATCC 25923 and Enterococcus faecalis ATCC
929212 were used as Gram-positive control strains.
Antimicrobial susceptibility testing
The VITEK-2 Gram-negative antimicrobial susceptibility
testing card (GN AST, bioMérieux, Inc.) was used to
determine the susceptibility of E. coli and Klebsiella spp.
isolates to different antimicrobial agents. E. coli ATCC
25922 was used as a control organism. VITEK 2 provides
AST results for antimicrobials as susceptible, intermedi-
ate susceptible, and resistant and is interpreted according
to CLSI criteria (10). In the present study, only resistant
results were presented.
ESBLs testing
Production of ESBLs by E. coli and Klebsiella spp. isolates
was determined phenotypically by VITEK 2 (bioMérieux,
Inc.). E. coli isolates positive for ESBLs phenotypically
were tested by PCR technique for ESBLs genes as
previously reported (11, 12). Briefly, whole cell lysate of
an overnight bacterial culture was prepared by boiling
method as described previously (13). Amplification was
done in a 50-ul reaction mixture containing 50 pmol
primers (as listed in Table 1), 0.25 mM deoxyribonucleo-
tide, 1.5 mM MgCl2, 1X GoTaq reaction buffer (Promega,
Madison, WI, USA), and 0.2 U GoTaq DNA polymerase.
Amplification conditions included 30 cycles of 958C for
30 sec, 558C for 1 min and 728C for 1 min. This was followed
by a final extension step at 728C 30 cycles. PCR products
were visualized by gel electrophoresis on a 2.0% agarose
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(Sigma-Aldrich, Steinheim, Germany) using 1X Tris-
acetate-EDTA buffer.
Statistical analysis
For statistical analysis, Epi Info 2000 software (Centers
for Disease Control and Prevention) was employed.
P-values were calculated using the Chi-square test.
PB0.05 was considered to be statistically significant.
Results
The present study enrolled 1,790 patients (1,151 females
and 639 males) with UTIs. The age of the patients ranged
from 3 days to 93 years (mean 25 years). Of these
patients, 1,134 were outpatients and 656 inpatients.
Uropathogens were isolated from 371 (20.7%) urine
specimens examined. Co-infection was determined in two
patient’s urine specimens as two different organisms were
isolated from each of them with a total of 373 uropathogens
being isolated. Predominance of E. coli and Klebsiella
spp. among isolated uropathogens was observed at 55.8%
(208/373) and 18.5% (69/373), respectively. Table 2 shows
the uropathogens isolated from patients with UTIs
attending ZTH.
According to gender and type of hospital admission,
E. coli and total uropathogens were significantly detected
in female patients compared with male patients and in
outpatients compared with inpatients with UTIs. Distribu-
tion of E. coli, Klebsiella spp., and other uropathogens
isolated from patients with UTIs according to gender and
to type of hospital admission is shown in Table 3.
Only E. coli and Klebsiella spp. isolates were tested for
antimicrobial susceptibility and ESBL production. Of the
E. coli and Klebsiella spp. tested, 69.2 and 100% were
resistant to ampicillin, 30.8 and 31.9% to ampicillin/
sulbactam, 6.7 and 33.3% to ceftriaxone, 23.1 and 17.4%
to ciprofloxacin, and 37 and 24.6% to trimethoprim/
sulfamethoxazole, respectively. Nitrofurantoin showed
good activity against E. coli isolates (1.9% resistant) but
not against Klebsiella spp. (30.4% resistant). Table 4 shows
the antimicrobial resistance patterns of E. coli and
Klebsiella spp. from patients with UTIs attending ZTH.
From Table 4 it can be observed that Klebsiella spp. isolates
were significantly more resistant to most of the antimicro-
bial agents tested than E. coli isolates. In addition, multi-
drug resistance (MDR, resistance to three or more
antimicrobial groups) was found in 69 (33.2%) of 208
E. coli isolates and in 29 (42%) of 69 Klebsiella spp. isolates.
ESBLs were detected in 6.7% (14/208) of E. coli and in
21.7% (15/69) of Klebsiella spp. isolates using phenotypic
procedure. The detection rate of ESBLs among Klebsiella
spp. is significantly higher than the detection rate of
Table 1. Polymerase chain reaction (PCR) primer sequences for the detection of extended-spectrum b-lactamases genes in
E. coli
Target gene Oligonucleotide primer sequences (5? to 3?) Amplicon size (bp) Reference
blaTEM-1F CAGCGGTAAGATCCTTGAGA 643 11
blaTEM-1R ACTCCCCGTCGTGTAGATAA
blaSHV-1F GGCCGCGTAGGCATGATAGA 714 11
blaSHV-1R CCCGGCGATTTGCTGATTTC
blaOXA-1F AATGGCACCAGATTCAACTT 599 11
blaOXA-1R CTTGGCTTTTATGCTTGATG
blaCTX-M-1F GAAGGTCATCAAGAAGGTGCG 560 12
blaCTX-M-1R GCATTGCCACGCTTTTCATAG
Table 2. Uropathogens isolates from patients (n1,790)
with UTIs
Organism No. (%) positive
E. coli 208 (12)
Klebsiella spp. 69 (3.8)
K. pneumoniae 67 (3.7)
K. oxytoca 2 (0.1)
Enterobacter spp. 18 (1.0)
E. aerogenes 5 (0.3)
E. cloacae 13 (0.7)
Proteus mirabilis 22 (1.2)
Citrobacter spp. 12 (0.7)
C. freundii 5 (0.3)
C. koseri 7 (0.4)
Morganella morganii 6 (0.3)
Serratia marcescens 1 (0.05)
Aeromonas hydrophila/caviae 1 (0.05)
Pseudomonas aeruginosa 4 (0.2)
Acinetobacter spp. 8 (0.4)
A. baumannii 6 (0.3)
A. haemolyticus 1 (0.05)
A. lwoffii 1 (0.05)
Staphylococcus spp. 14 (0.8)
Enterococcus faecalis 4 (0.2)
Streptococcus agalactiae 6 (0.3)
Total 373 (20.8)a
aIn two patients, two different organisms were isolated from each
of them.
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ESBLs among E. coli isolates (PB0.0005, OR3.85).
Thirteen of the 14 phenotypically ESBLs-positive E. coli
were positive for ESBLs genes by PCR. blaTEM gene was
detected in seven isolates, blaOXA gene in 10 isolates and
blaCTX-M gene in six isolates (Fig. 1). blaSHV gene was not
detected in the present study. Combination of two ESBL
genes in a single isolate occurred in four isolates (blaTEM
and blaOXA in 1, blaTEM and blaCTX-M in 2, and blaOXA
and blaCTX-M in 1) and three ESBL genes combination
in three isolates (blaTEM, blaOXA, and blaCTX-M in 3).
Distribution of ESBLs genes among 14 phenotypically
ESBLs-positive E. coli from patients with UTI is shown
in Supplementary Table 1.
Discussion
In the present investigation, uropathogens were detected
in more than 20% of patients with UTIs attending ZTH
with a predominance of E. coli and Klebsiella spp. Pre-
vious studies from different countries reported different
rates of uropathogens among patients with UTIs. A study
from Kuwait reported uropathogens in 9.2% (4,696/
51,562) that cause UTIs in two large teaching hospitals
over a period of 1 year (14). The authors reported the
predominance of E. coli (47%) followed by Candida spp.
(10.8%) and Klebsiella spp. (9.6%). Bercion et al. (15)
performed a retrospective analysis of all cases of con-
firmed UTIs due to Enterobacteriaceae in outpatients
attending the Institut Pasteur de Bangui, Central African
Republic, between 2004 and 2006. They found bacterial
pathogens in 560 of the 5,128 (10.9%) patients with
predominance of E. coli (64%) and Klebsiella spp. (10%).
Kashef et al. (16) examined 13,333 mid-stream urine
samples collected from suspected cases of UTI in Tehran,
Iran. Uropathogens were found in 6.3% (840/13,333) with
Table 3. Distribution of E. coli, Klebsiella spp., and other uropathogens isolated from patients with UTIs according to gender
and type of hospital admission
No. (%) positive
Organism Female (n1,151) Male (n639) Outpatients (n1,134) Inpatients (n656)
E. coli 163 (14.2)a 45 (7.0) 155 (13.7)b 53 (8.1)
Klebsiella spp. 43 (3.7) 26 (4.1) 41 (3.6) 28 (4.3)
Other bacteria 65 (5.6) 31 (4.9) 68 (6.0) 28 (4.3)
Total 271 (23.5)c 102 (16) 264 (23.3)d 109 (16.6)
aSignificantly higher than in male patients (PB0.000007, odds ratio [OR]2.18); bsignificantly higher than in inpatients (PB0.0004,
OR1.80); csignificantly higher than in male patients (PB0.0002, OR1.62); dsignificantly higher than in inpatients (PB0.0009,
OR1.52).
Table 4. Antimicrobial resistance patterns of E. coli and Klebsiella spp. from patients with UTIs
No. (%) resistant to
Antimicrobial agent E. coli (n208) Klebsiella spp. (n69) P (odds ratio)
Ampicillin 144 (69.2) 69 (100) 0.0000001 (Undefined)
Ampicillin/sulbactam 64 (30.8) 22 (31.9) NS
Cefazoline 45 (21.6) 26 (37.7) B0.008 (2.19)
Cefoxitin 8 (3.8) 4 (5.8) NS
Ceftazidime 14 (6.7) 22 (31.9) 0.0000001 (6.49)
Ceftriaxone 14 (6.7) 23 (33.3) 0.0000000 (6.93)
Cefepime 13 (6.3) 22 (31.9) 0.0000000 (7.02)
Imipenem 1 (0.5) 4 (5.8) B0.005 (12.74)
Meropenem 1 (0.5) 3 (4.3) B0.02 (9.41)
Amikacin 0 (0.0) 1 (1.4) NS
Gentamicin 23 (11.1) 16 (23.2) B0.02 (2.43)
Tobramycin 17 (8.2) 9 (13) NS
Ciprofloxacin 48 (23.1) 12 (17.4) NS
Levofloxacin 40 (19.2) 9 (13) NS
Nitrofurantoin 4 (1.9) 21 (30.4) 0.0000000 (22.31)
Trimethoprim/sulfamethoxazole 77 (37) 17 (24.6) NS
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a predominance of E. coli (68.8%, 578/840) followed by
Proteus spp. (12.4%, 104/840), and Klebsiella spp. (9.6%,
81/840).
Other uropathogens isolated from ZTH patients in-
clude P. mirabilis (5.9%), Enterobacter spp. (4.8%), and
Citrobacter spp. (3.2%). A study from Ife, Nigeria
reported uropathogens in 36 (12%) of the 301 patients
with UTIs (17). The majority of 36 bacterial isolates
obtained were E. coli leading to 52.8% of the cases of
UTIs, followed by Klebsiella spp. (25%), P. mirabilis
(13.9%), Strep.(Enterococcus) faecalis (5.6%), and Ps.
aeruginosa (2.8%).
We found E. coli and total uropathogens were signifi-
cantly isolated from female patients compared to male
patients (Table 3). Other investigators found no significant
difference in the distribution of isolated uropathogens
between genders (15, 18). However, an Iranian study
reported that E. coli occurred significantly more frequently
in women (76.5% in women compared to 62.4% in men;
PB0.05), whereas the prevalence of UTIs due to K.
pneumoniae and Ps. aeruginosa was higher in men than in
women (22.6 and 7.5% in men compared to 9.9 and 1.4% in
women, respectively; PB0.01) (19). No significant differ-
ences (P0.05) in the distribution of Klebsiella spp. and
other uropathogens between genders were observed in this
study. Also, E. coli and total uropathogens were signifi-
cantly isolated from outpatients than from inpatients with
UTIs frequenting ZTH. Other studies found no significant
difference in the isolation of uropathogens from out-
patients and inpatients with UTIs (20).
Differences in the reported isolation rates of uropatho-
gens from different regions may be due to differences in
age, gender and number of patients examined, types of
uropathogens examined (e.g. some studies did not include
Candida spp. in their search as in the present study), and
types and number of media used in the isolation of
uropathogens. Some studies used blood and MacConkey
agars (present study) or blood agar and eosin methylene
blue agar plates (16). Other studies used only bromocresol
purple agar (15).
In the present study, antimicrobial susceptibility testing
showed high resistance rates to ampicillin among E. coli
and Klebsiella spp. isolates. However, lower resistance rates
than previously reported from Libya to trimethoprim/
sulfamethoxazole among E. coli (37%) and Klebsiella spp.
(24.6%) were observed. In the mid-1990s, Ghenghesh et al.
examined 538 E. coli isolates from patients with UTIs in
Tripoli for their susceptibility to antimicrobial agents (8).
Of the isolates examined 74% were resistant to ampicillin,
7% to gentamicin, 25% to nitrofurantoin, and 45% to
trimethoprim/sulfamethoxazole. Tobgi et al. tested the
susceptibility of 148 E. coli isolated from urine specimens
from outpatients attending Al-Jalla Hospital in Benghazi
to antibiotics (9). They reported that 75% of them were
resistant to ampicillin, 18% to gentamicin and 81% to
trimethoprim/sulfamethoxazole.
The lower rates observed with trimethoprim/sulfa-
methoxazole may be due to less use of the drug in treating
bacterial infections (including UTIs) in Libya. Newer
antibiotics like third generation cephalosporins (e.g.
ceftriaxone and cefotaxime) and fluoroquinolones (e.g.
ciprofloxacin and norfloxacin) have been more widely used
in recent years. This observation can be supported by the
findings of the present investigation of high resistance rates
to ciprofloxacin among E. coli and Klebsiella spp., and to
the cephalosporins such as ceftazidime, ceftriaxone, and
cefepime among Klebsiella spp. (Table 4).
Studies from other countries also reported high resis-
tance rates to different classes of antimicrobials. A study
from Mexico examined 119 E. coli isolates obtained from
Fig. 1. PCR products of blaCTX-M (lines 18 and 914); L 100 bp ladder and 50 bp ladder. pospositive control and
negnegative control.
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urine specimens of outpatients with clinical diagnosis of
uncomplicated UTIs from 2004 to 2007 (21). Resistance to
ampicillin was found in 83.7% of the isolates, to the
fluoroquinolone group (i.e. ciprofloxacin, nalidixic acid,
ofloxacin, and norfloxacin) in 55.560.6%, and to tri-
methoprim/sulfamethoxazole in 56.4%. In addition, 30.2%
of isolates were multidrug-resistant.
MDR was detected in 32.2% of E. coli and 42% of
Klebsiella spp. isolated from patients with UTIs attending
ZTH. Alzohairy and Khadri reported higher rates of
MDR among E. coli (53.6%) and Klebsiella spp. (50%)
isolated from community and hospital-acquired UTIs in
Qassim province, Saudi Arabia (22).
A previous study from Benghazi examined 119 strains
of E. coli isolated from patients with UTIs (14 from HIV-
positive patients) for ESBLs production using phenotypic
method (23). Only four (3.4%) E. coli strains (two from
HIV-negative and two from HIV-positive patients) were
found positive for ESBLs. In the present study, ESBLs
were detected at a higher rate of 6.7% among E. coli
isolates from patients with UTIs attending ZTH using
phenotypic techniques.
Other investigators from the Middle East and Africa
reported similar findings. A study from Saudi Arabia
reported ESBLs in 6.1% (570/9,409) (24). ESBLs were
detected in 8.1% (29/357) of E. coli strains isolated from
outpatients with suspected uncomplicated UTIs in Cen-
tral African Republic (15). However, much higher rates of
ESBLs have been reported from other countries in Africa.
Ejikeugwu et al. examined a total of 83 non-duplicate
Escherichia coli isolates from urine specimens of patients
suspected of having community-acquired UTIs in Enugu
State, Nigeria, from August 2010 to July 2011 (25). They
detected ESBLs in 23 (27.7%) of the isolates investigated
using the double disk synergy test method. Although the
prevalence of ESBLs-producing bacteria is a worldwide
problem, the geographical distribution can vary accord-
ing to countries and institutions (26).
Several studies suggested that urine can be an im-
portant source of ESBLs-producing E. coli (27, 28). To
our knowledge, this the first report of ESBLs detection in
E. coli isolates from UTIs in Libya using PCR. Pre-
dominance of blaOXA (10/13) followed by blaTEM (7/13)
and blaCTX-M (6/13) was observed in this study. Bourjilat
et al. detected seven (1.3%) ESBLs-producing E. coli
among 535 E. coli isolates from urine specimens of
patients with community-acquired urinary infections in
Casablanca, Morocco, during July 2004 to July 2007 (29).
Employing PCR the investigators detected genes encod-
ing blaCTX-M in most of them (6/7).
The findings of this study showed that E. coli and
Klebsiella spp. were the predominant uropathogens caus-
ing UTIs in patients frequenting ZTH. High rates of
resistance to commonly used and newer antimicrobial
agents were observed among these organisms; with
Klebsiella spp. isolates being significantly more resistant
to these drugs than E. coli isolates. ESBLs and high rates of
MDR were observed in E. coli and Klebsiella spp. isolates.
In addition, genes coding for ESBLs were detected in
E. coli using PCRwith a predominance of blaOXA followed
by blaTEM and blaCTX-M.
The isolation of MDR ESBLs-producing uropathogens
from UTIs patients undoubtedly will limit the choices
clinicians have to treat their patients. Of the antimicrobial
tested imipenem, meropenem, amikacin, and cefoxitin
showed excellent activity against both E. coli and Klebsiella
spp. isolates. In addition, third generation cephalosporins
and nitrofurantoin demonstrated good activity against
E. coli isolates. However, treatment should be guided by
the results of antimicrobial susceptibility testing for each
individual patient.
Antimicrobial resistance among uropathogens is a
serious health problem. Education of clinicians and other
healthcare workers on the health risks associated with the
problem and on the benefits of prudent use of anti-
microbials will help in tackling such a problem. Further-
more, there is an urgent need for surveillance studies on
antimicrobial resistance and prevalence of ESBLs among
uropathogens to guide the clinical treatment of UTIs in
Libya in the future.
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